Evaluation of Fluorescein Diacetate Viability Staining during Treatment Follow-up Examinations of Smear Positive Pulmonary Tuberculosis Patients
FDA viability staining proved to be a better predictor of bacteriological clearance during follow-up examinations of patients on antitubercular therapy and may be explored in future research.
Authors
- Ujjwala Gaikwad (ORCID: https://orcid.org/0000-0002-9869-2839)
- Anudita Bhargava (ORCID: https://orcid.org/0000-0001-6079-5421)
- Sachin Chandraker
- Padma Das (ORCID: https://orcid.org/0000-0002-7497-5113)
- Tushar Jagzape
- Ajoy Kumar Behera
Institutions
- All India Institute of Medical Sciences Raipur (IN)
Publication Details
- Journal
- International Journal of Mycobacteriology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4103/ijmy.ijmy_220_24
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00